{"id":36,"date":"2022-02-16T19:08:41","date_gmt":"2022-02-16T19:08:41","guid":{"rendered":"https:\/\/epilepsycoloradowyoming.org\/?page_id=28"},"modified":"2022-02-16T19:08:41","modified_gmt":"2022-02-16T19:08:41","slug":"advocacy","status":"publish","type":"page","link":"https:\/\/test.boomerangdev.us\/index.php\/make-a-difference\/advocacy\/","title":{"rendered":"Advocacy"},"content":{"rendered":"<p>[vc_row content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1646414696274{margin-bottom: 36px !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]<\/p>\n<h4>The Epilepsy Foundation of Colorado &amp; Wyoming is committed to serving the best interests of people with epilepsy, their family members and caregivers and proudly advocates:<\/h4>\n<ul>\n<li>Funding for epilepsy programs, research, and a cure<\/li>\n<li>Policies that promote research and innovation<\/li>\n<li>Improving access to and coverage of quality care and essential services<\/li>\n<li>The protection of the rights of individuals with disabilities.<\/li>\n<\/ul>\n<p>These broad goals guide both our federal and state advocacy activities.[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;131&#8243; alignment=&#8221;center&#8221;][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; css=&#8221;.vc_custom_1646339308744{background-color: #efedf2 !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]<\/p>\n<h2>Epilepsy Foundation Advocacy Priorities<\/h2>\n<p>We are working to secure more funding for a cure, support community-based programs for people living with epilepsy, eradicate stigma and discrimination, and protect patient access to medications and treatment. To learn more about our policy priorities, visit\u00a0<a href=\"https:\/\/www.epilepsy.com\/about-us\/advocacy\/advocacy-priorities\">https:\/\/www.epilepsy.com\/about-us\/advocacy\/advocacy-priorities<\/a>.[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_column_text]<\/p>\n<div>\n<h2>Funding For Epilepsy Programs, Research, and a Cure<\/h2>\n<\/div>\n<p>The Epilepsy Foundation supports funding increases for epilepsy research at the National Institutes of Health (NIH); epilepsy programs at the Centers for Disease Control and Prevention (CDC) focused on building safer communities for people living with epilepsy; and\u00a0promoting safety, efficacy and research at the Food and Drug Administration (FDA).<\/p>\n<div><a href=\"http:\/\/advocacy.epilepsy.com\/efa\/federal-funding-for-epilepsy\">Learn more about federal funding for epilepsy research and programs.<\/a><\/div>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row css=&#8221;.vc_custom_1646414708906{margin-top: 36px !important;}&#8221;][vc_column][vc_column_text css=&#8221;&#8221;]<\/p>\n<h1><strong>Access to Care<\/strong><\/h1>\n<p>Timely access to appropriate care and effective coverage for epilepsy medications is a critical concern for people living with epilepsy, because epilepsy medications are the most common and most cost-effective treatment for controlling and\/or reducing seizures. Individuals living with epilepsy who experience a delay in accessing their medication due to prior authorization and step therapy requirements, high cost-sharing, medication substitutions without physician and patient consent, and onerous drug monitoring requirements, are at a high risk for developing breakthrough seizures and related complications, including Sudden Unexpected Death in Epilepsy (SUDEP). <a href=\"https:\/\/www.epilepsy.com\/about-us\/advocacy\/advocacy-priorities\/access-care\" target=\"_blank\" rel=\"noopener\">Learn more about our advocacy on access to care issues.<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row content_placement=&#8221;middle&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;164&#8243; alignment=&#8221;center&#8221;][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_column_text]<\/p>\n<h1><strong>Research and Innovation<\/strong><\/h1>\n<p>Innovation is of particular importance to the nearly one million people living with epilepsy who don\u2019t have their seizures under control and are seeking new treatments and a cure, as well as many Americans living with complex chronic and rare conditions that are not appropriately managed with current treatment options. <a href=\"https:\/\/www.epilepsy.com\/research-funding\">Learn more.\u00a0<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; css=&#8221;.vc_custom_1646339427842{padding-bottom: 24px !important;background-color: #efedf2 !important;}&#8221;][vc_column][vc_column_text]<\/p>\n<h1><strong>Disability and Discrimination<\/strong><\/h1>\n<p>Stigma surrounding epilepsy continues to fuel discrimination and isolates people with epilepsy from the mainstream of life. Despite great progress in recent years, epilepsy remains a formidable barrier to educational opportunities, employment, and personal fulfillment among older children and adults. <a href=\"https:\/\/www.epilepsy.com\/about-us\/advocacy\/advocacy-priorities\/disability-discrimination\">Learn more about the Epilepsy Foundation\u2019s disability and discrimination advocacy.<\/a>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1646414696274{margin-bottom: 36px !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text] The Epilepsy Foundation of Colorado &amp; Wyoming is committed to serving the best interests of people with epilepsy, their family members and caregivers and proudly advocates: Funding for epilepsy programs, research, and a cure Policies that promote research and innovation Improving access to and coverage of quality care and &#8230; <a title=\"Advocacy\" class=\"read-more\" href=\"https:\/\/test.boomerangdev.us\/index.php\/make-a-difference\/advocacy\/\" aria-label=\"Read more about Advocacy\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":23,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","footnotes":""},"class_list":["post-36","page","type-page","status-publish"],"acf":[],"taxonomy_info":[],"featured_image_src_large":false,"author_info":{"display_name":"boomerang","author_link":"https:\/\/test.boomerangdev.us\/index.php\/author\/boomerang\/"},"comment_info":0,"_links":{"self":[{"href":"https:\/\/test.boomerangdev.us\/index.php\/wp-json\/wp\/v2\/pages\/36","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.boomerangdev.us\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/test.boomerangdev.us\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/test.boomerangdev.us\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/test.boomerangdev.us\/index.php\/wp-json\/wp\/v2\/comments?post=36"}],"version-history":[{"count":0,"href":"https:\/\/test.boomerangdev.us\/index.php\/wp-json\/wp\/v2\/pages\/36\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/test.boomerangdev.us\/index.php\/wp-json\/wp\/v2\/pages\/23"}],"wp:attachment":[{"href":"https:\/\/test.boomerangdev.us\/index.php\/wp-json\/wp\/v2\/media?parent=36"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}